• 1
    Leontides LS, Saridomichelakis MN, Billinis C, et al. A cross-sectional study of Leishmania spp. infection in clinically healthy dogs with polymerase chain reaction and serology in Greece. Vet Parasitol 2002;109:1927.
  • 2
    Slappendel RJ. Canine leishmaniasis. A review based on 95 cases in The Netherlands. Vet Q 1988;10:116.
  • 3
    Koutinas AF, Polizopoulou ZS, Saridomichelakis MN, et al. Clinical considerations on canine visceral leishmaniasis in Greece: A retrospective study of 158 cases (1989–1996). J Am Anim Hosp Assoc 1999;35:376383.
  • 4
    Ciaramella P, Oliva G, Luna RD, et al. A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum. Vet Rec 1997;141:539543.
  • 5
    Mylonakis ME, Saridomichelakis MN, Lazaridis V, et al. A retrospective study of 61 cases of spontaneous canine epistaxis (1998–2001). J Small Anim Pract 2007; 191196.
  • 6
    Juttner C, Rodriguez SM, Rollan LE, et al. Evaluation of the potential causes of epistaxis in dogs with natural visceral leishmaniasis. Vet Rec 2001;149:176179.
  • 7
    Brassard JA, Meyers KM. Evaluation of buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: The effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency. Thromb Haemostas 1991;65:191195.
  • 8
    Tseng LW, Hughes D, Giger U. Evaluation of a point-of-care coagulation analyser for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs. Am J Vet Res 2001;62:14551460.
  • 9
    Mischke R, Menzel D. Measuring fibrinogen concentrations in healthy dogs: Standardization, comparison of methods and reference values. Zentralbl Veterinarmed A 1994;41:587598.
  • 10
    Brassard JA, Meyers KM, Person M, Dhein CR. Experimentally induced renal failure in the dog as an animal model of uremic bleeding. J Lab Clin Med 1994;124:4854.
  • 11
    Werner LL, Turnwald GH. Immunologic and plasma protein disorders. In: WillardMD, TvedtenH, TurnwaldGH, eds. Small Animal Clinical Diagnosis by Laboratory Methods. Philadelphia, PA: Saunders; 1999:248264.
  • 12
    Day MJ, Penhale WJ. Humoral immunity in disseminated Aspergillus terreus infection in the dog. Vet Microbiol 1988;16:283294.
  • 13
    Harrus S, Waner T, Aizenberg I, et al. Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis. J Clin Microbiol 1998;36:7376.
  • 14
    Diniz PPVP, Maggi RG, Schwartz DS, et al. Canine bartonellosis: Serological and molecular prevalence in Brasil and evidence of co-infection with Bartonella henselae and Bartonella vinsonii subsp. berkhoffii. Vet Res 2007;38:697710.
  • 15
    Whitley E, Ball J. Statistics review 2: Samples and populations. Crit Care 2002;6:143148.
  • 16
    Brown SA, Henik RA. Therapy for systemic hypertension in dogs and cats. In: BonaguraJD, ed. Kirk's Current Veterinary Therapy XIII Small Animal Practice. Philadelphia, PA: Saunders; 2000:838841.
  • 17
    Cortadellas O, Del Palacio MJF, Bayon A, et al. Systemic hypertension in dogs with leishmaniasis: Prevalence and clinical consequences. J Vet Intern Med 2006;20:941947.
  • 18
    Abranches P, Santos-Gomes G, Rachamim N, et al. An experimental model for canine visceral leishmaniasis. Parasite Immunol 1991;13:537550.
  • 19
    Valladares JE, Ruiz De Gopegui R, Riera C, et al. Study of haemostatic disorders in experimentally induced leishmaniasis in Beagle dogs. Res Vet Sci 1998;64:195198.
  • 20
    Campino L, Santos-Gomes G, Rica Capela MJ, et al. Infectivity of promastigotes and amastigotes of Leishmania infantum in a canine model for leishmaniasis. Vet Parasitol 2000;92:269275.
  • 21
    Poot J, Rogers ME, Bates PA, Vermeulen A. Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs. Vet Parasitol 2005;130:4153.
  • 22
    Moreno P. Evaluation of secondary haemostasis in canine leishmaniasis. Vet Rec 1999;144:169171.
  • 23
    Moreno P, Lucena R, Ginel PJ. Evaluation of primary haemostasis in canine leishmaniasis. Vet Rec 1998;142:8183.
  • 24
    Corona M, Ciaramella P, Pelagalli A, et al. Haemostatic disorders in dogs naturally infected by Leishmania infantum. Vet Res Commun 2004;28 (Suppl 1):331334.
  • 25
    Pelagalli A, Ciaramella P, Lombardi P, et al. Evaluation of adenosine 5′-diphosphate (ADP)- and collagen-induced platelet aggregation in canine leishmaniasis. J Comp Pathol 2004;130:124129.
  • 26
    Ciaramella P, Pelagalli A, Cortese L, et al. Altered platelet aggregation and coagulation disorders related to clinical findings in 30 dogs naturally infected by Leishmania infantum. Vet J 2005;169:465467.
  • 27
    Castillo R, Lozano T, Escolar G, et al. Defective platelet adhesion on vessel subendothelium in uremic patients. Blood 1986;68:337342.
  • 28
    Brassard JA, Meyers KM. von Willebrand factor is not altered in azotemic dogs with prolonged bleeding time. J Lab Clin Med 1994;124:5562.
  • 29
    Font A, Closa JM, Mascort J. Monoclonal gammopathy in a dog with visceral leishmaniasis. J Vet Intern Med 1994;8:233235.
  • 30
    Amati F, Canellini G, Beris P. Polyclonal hypergammaglobulinemia with hyperviscosity syndrome. Br J Haematol 2002;116:2.
  • 31
    Giraudel JM, Pages JP, Guelfi JF. Monoclonal gammopathies in the dog: A retrospective study of 18 cases (1986–1999) and literature review. J Am Anim Hosp Assoc 2002;38:135147.
  • 32
    Stockham SL, Scott MA. Proteins. In: StockhamSL, ScottMA, eds. Fundamentals of Veterinary Clinical Pathology. Iowa City, IA: Iowa State Press; 2002:251276.
  • 33
    Garderet L, Fabiani B, Lacombe C, et al. Hyperviscosity syndrome in an HIV-1 positive patient. Am J Med 2004;117:891893.
  • 34
    Forrester SD, Rogers KS. Hyperviscosity syndrome. In: FeldmanBF, ZinklJG, JainNC, eds. Schalm's Veterinary Hematology. Baltimore, MD: Lippincot Williams & Wilkins; 2000:929931.
  • 35
    Miller C, Fish MB, Danelski TF. IgA multiple myeloma multi-system manifestations in the dog: A case report. J Am Anim Hosp Assoc 1982;18:5356.
  • 36
    Hammer AS, Couto CG. Complications of multiple myeloma. J Am Anim Hosp Assoc 1994;30:914.
  • 37
    Breitschwerdt EB, Hegarty BC, Maggi R, et al. Bartonella species as a potential cause of epistaxis in dogs. J Clin Microbiol 2005;43:25292533.
  • 38
    Henn JB, Liu C-H, Kasten RW, et al. Seroprevalence of antibodies against Bartonella species and evaluation of risk factors and clinical signs associated with seropositivity in dogs. Am J Vet Res 2005;66:688694.
  • 39
    Fuchs FD, Moreira LB, Pipes CP, et al. Absence of association between hypertension and epistaxis: A population-based study. Blood Pressure 2003;12:145148.
  • 40
    Pumarola M, Brevik L, Badiola J, et al. Canine leishmaniasis associated with systemic vasculitis in two dogs. J Comp Pathol 1991;105:279286.